The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney
disease (DKD) remains one of the leading long-term complications of T2D. Several lines of …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, involving approximately 25% of the general population and increasing in …

Abstract Val‐Val‐Tyr‐Pro (VVYP) peptide is one of the main active components of Globin
digest (GD). Our previous studies indicated that VVYP could protect against acetaminophen …

Objective To explore the relationship between non-alcoholic fatty liver disease (NAFLD) and
chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM). Methods A …

Background: The consumption of sweetened beverages is associated with increased risk of
metabolic syndrome, cardiovascular disease, and type 2 diabetes mellitus. Objective: We …

Background Health literacy is the ability to deal with information related to one's health.
Patients with low health literacy have poor disease-management skills for chronic diseases …

Non-alcoholic fatty liver disease (NAFLD) is a group of metabolic liver illnesses that lead to
accumulation of liver fat mainly due to excessive nutrition. It is closely related to insulin …

Background Metabolic syndrome is a growing twenty‐first century pandemic associated with
multiple clinical comorbidities ranging from cardiovascular diseases, non‐alcoholic fatty liver …

Background The exact pathophysiological mechanisms of SGLT‐2 inhibitors in the
development, progression or treatment of malignancies are not fully understood, but multiple …

Background Nonalcoholic fatty liver disease (NAFLD) is associated with impaired renal
function, and both diseases often occur alongside other metabolic disorders. However, the …